Skip to main content
. Author manuscript; available in PMC: 2022 May 4.
Published in final edited form as: J Drug Target. 2011 Dec;19(10):915–924. doi: 10.3109/1061186X.2011.623701

Figure 2.

Figure 2.

GNR binding and uptake by (A) high-resolution dark field microscopy and (B) ICP-MS after 24 h incubation with either RGDfK modified or untargeted GNRs (10 μg/mL). RGDfK-GNRs show increased binding and uptake relative to untargeted GNRs in both cell lines; however, this difference was most significant (roughly 20-fold) with HUVECs.